anuary 05, 2025 03:05 PM Eastern Standard Time GLASGOW, Scotland–(BUSINESS WIRE)–In what will be a worldwide wearables first, Novosound is set to demonstrate ultrasound blood pressure monitoring at CES 2025 in Las Vegas between 7th-10th January, with the company revealing how it has been able to achieve accuracy levels comparable to conventional electronic cuff […]
Other News
Vitestro Appoints Bob Gerberich as Chief Commercial Officer for North America
Seasoned MedTech Executive to Lead U.S. Launch of Vitestro’s Autonomous Robotic Blood-Draw Device UTRECHT, Netherlands, Jan. 6, 2025 /PRNewswire/ — Vitestro, a pioneer in autonomous robotic venous access and blood drawing, today announced the appointment of Bob Gerberich as Chief…
Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care
TORONTO, Jan. 6, 2025 /PRNewswire/ — Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease…
Stroke Detection Innovator Wellumio Expands into the U.S. Market
Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical ‘golden hour.’ SAN FRANCISCO, Jan. 6, 2025 /PRNewswire/ — Wellumio, a New…
SandboxAQ’s AQMed Reflects on a Year of Scientific and Technical Achievements
– Developed first-of-its-kind unshielded MCG device for bedside use, published in MDPI Sensors – Presented AI applications in MCG at Frontiers of Cardiovascular Medicine special issue – Breakthrough clinical results on N-STEMI diagnostics presented at AHA Scientific Sessions – Launched…
Inari Medical to Present at the J.P. Morgan Healthcare Conference
IRVINE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other vascular diseases, announced today that its management team is scheduled to present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 8:15 a.m. Pacific Time.
Viper Partners Drives Strategic Growth in Vascular Surgery Practices
PALM BEACH, Fla., Jan. 3, 2025 /PRNewswire/ — Viper Partners, a premier leader in healthcare investment banking, announces its continued commitment to the growth and advancement of vascular surgery practices nationwide. By facilitating strategic mergers and acquisitions, Viper Partners…
Coro Medical Prepares to Roll Out Project AED365 Nationwide Donation Initiative
Project AED365 Aims to Empower Communities, Youth Organizations, First Responders, and more by Providing Lifesaving Automated External Defibrillators (AEDs) Alongside Comprehensive Emergency Training and Equipment to Address Sudden Cardiac Arrest FRANKLIN, Tenn., Dec. 30, 2024…
CardioSight, Inc appoints Niv Ad, M.D. as Chief Medical Officer
BUDAPEST, Hungary, Dec. 30, 2024 /PRNewswire/ — CardioSight, Inc., developer of a revolutionary intravascular visualization and interventional platform, announces the appointment of Niv Ad, M.D., as Chief Medical Officer. Dr. Ad is an internationally renowned leader in cardiothoracic…
NAVIGANTIS VASCO™ Robotic Platform Used with First Patients Enrolled in Neurovascular Study
MIAMI, Dec. 27, 2024 /PRNewswire/ — Navigantis Inc. announced today the first successful neurovascular clinical cases performed with its VASCO interventional robotic platform for patients suffering from neurovascular disorders. “This achievement marks an important milestone in our…



